Petco Health and Wellness Company (WOOF) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for July 24, 2025, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials online and vote by July 23, 2025.
Voting matters and shareholder proposals
Election of three Class II directors: R. Michael Mohan, David Lubek, and Christopher J. Stadler, with board recommending a vote for all nominees.
Advisory vote to approve executive compensation for named executive officers.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending January 31, 2026.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Board recommends all director nominees for election to Class II positions.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Petco Health and Wellness Company
- Profitability and cash flow surged in 2025, with leverage ratio reduced to 3.0x.WOOF
Q4 202611 Mar 2026 - Q2 revenue fell, losses widened, and cost discipline intensified amid macroeconomic headwinds.WOOF
Q2 202521 Jan 2026 - Q3 revenue grew 1.2%, margin improved, and positive free cash flow is on track.WOOF
Q3 202511 Jan 2026 - Q4 2024 comp sales rose and free cash flow turned positive, but revenue and EBITDA declined.WOOF
Q4 202526 Dec 2025 - Profitability and cash flow improved in Q3 2025, despite a 3.1% sales decline.WOOF
Q3 20265 Dec 2025 - Board recommends approval of all proposals, emphasizing governance, pay-for-performance, and ESG.WOOF
Proxy Filing1 Dec 2025 - Joel D. Anderson named CEO effective July 29, 2024, with expanded Board and updated leadership.WOOF
Proxy Filing1 Dec 2025 - Q2 2025 saw higher margins and earnings despite lower sales, with guidance raised.WOOF
Q2 202623 Nov 2025 - Adjusted EBITDA rose to $89.4M as margins improved despite lower sales and reaffirmed guidance.WOOF
Q1 202612 Nov 2025